KANEKA The Dreamology Company -Make your dreams come true-

Introducing Kaneka's Technologies and Products to Fight Novel Coronavirus!

Novel coronavirus is affecting and threatening people's lives around the world.
Kaneka is helping to protect people's health from novel coronavirus in a number of fields.

Kaneka’s technologies and products that help fight novel coronavirus

Testing

PCR reagents

At the request of the Belgian government, Kaneka Eurogentec has been supplying PCR reagents for novel coronavirus testing in Belgium and surrounding countries since April 2020, when novel coronavirus infection began to spread.

PCR test kit

Kaneka has developed a test kit that can detect novel coronavirus in approximately one hour based on its proprietary sample processing technology.

Treatment

Active Pharmaceutical Ingredient for Avigan® Tablet

Kaneka supplies the active pharmaceutical ingredient for FUJIFILM Toyama Chemical Co., Ltd.'s Avigan® tablets, which show strong potential for treating novel coronavirus.

Avigan® is a registered trademark of FUJIFILM Toyama Chemical Co., Ltd.

Materials for disposable medical gloves

Disposable gloves are needed in medical facilities worldwide.
Kaneka's heat-stable and processable paste PVC is used in these gloves to protect the lives of front-line medical professionals.

Related page

Prevention

Vaccines

Kaneka responds to requests from domestic and overseas pharmaceutical manufacturers for contract manufacturing using Kaneka Eurogentec's plasmid DNA and mRNA-related technologies.

Kaneka's Initiatives

'Medical domain (PCR test kit / Blood purification technology)' 'Small molecule pharmaceutical domain (Active Pharmaceutical Ingredient for Avigan® Tablet)' 'Biopharmaceutical domain (Antibody drugs / DNA, mRNA vaccine / PCR reagents)' 'Supplement domain (Reduced form of coenzyme Q10)' 'Medical domain (PCR test kit / Blood purification technology)' 'Small molecule pharmaceutical domain (Active Pharmaceutical Ingredient for Avigan® Tablet)' 'Biopharmaceutical domain (Antibody drugs / DNA, mRNA vaccine / PCR reagents)' 'Supplement domain (Reduced form of coenzyme Q10)'

Medical domain
(PCR test kit / Blood purification technology)

Small molecule pharmaceutical domain
(Active Pharmaceutical Ingredient for Avigan® Tablet)

Biopharmaceutical domain
(Antibody drugs / DNA, mRNA vaccine / PCR reagents)

Supplement domain
(Reduced form of coenzyme Q10)

Among Kaneka’s various technologies, the field of biotechnology related business has a strong connection to our daily lives, including food, medicine, and the environment. In order to maximize the use of these technologies and introduce them to society in unique ways from a big picture perspective, Kaneka established the Infection Initiative Team as a cross-organizational emergency team working on countermeasures for infectious diseases.

Avigan® is a registered trademark of FUJIFILM Toyama Chemical Co., Ltd.

What Kaneka can do for the future

We humans must learn to live with viruses.
At a time when health and safety are more important than ever,
Kaneka is focusing its management resources on the healthcare business to achieve further growth,
contribute to society and make the world a healthier place.
Kaneka is committed to supporting a society that nurtures life.